Sandra Mayer
Overview
Explore the profile of Sandra Mayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boelig R, Chaudhury S, Gromowski G, Mayer S, King J, Aghai Z, et al.
Front Immunol
. 2023 Sep;
14:1216410.
PMID: 37753075
Introduction: As the SARS-CoV-2 pandemic continues to evolve, we face new variants of concern with a concurrent decline in vaccine booster uptake. We aimed to evaluate the difference in immunity...
2.
Gromowski G, Cincotta C, Mayer S, King J, Swafford I, McCracken M, et al.
EBioMedicine
. 2023 Jul;
94:104683.
PMID: 37413891
Background: COVID-19 vaccines have been critical for protection against severe disease following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) but gaps remain in our understanding of the immune...
3.
Shrivastava S, Carmen J, Lu Z, Basu S, Sankhala R, Chen W, et al.
NPJ Vaccines
. 2023 Mar;
8(1):43.
PMID: 36934088
This study demonstrates the impact of adjuvant on the development of T follicular helper (Tfh) and B cells, and their influence on antibody responses in mice vaccinated with SARS-CoV-2-spike-ferritin-nanoparticle (SpFN)...
4.
Balasubramaniyam A, Ryan E, Brown D, Hamza T, Harrison W, Gan M, et al.
Vaccines (Basel)
. 2023 Jan;
11(1).
PMID: 36679887
The emergence of novel potentially pandemic pathogens necessitates the rapid manufacture and deployment of effective, stable, and locally manufacturable vaccines on a global scale. In this study, the ability of...
5.
Rommel C, Rosner S, Lother A, Barg M, Schwaderer M, Gilsbach R, et al.
Circ Res
. 2018 Jun;
123(5):550-563.
PMID: 29930145
Rationale: Structural and electrophysiological remodeling of the atria are recognized consequences of sustained atrial arrhythmias, such as atrial fibrillation. The identification of underlying key molecules and signaling pathways has been...
6.
7.
Mayer S, Roeser M, Lachmann P, Ishii S, Suh J, Harlander S, et al.
J Biol Chem
. 2012 May;
287(29):24483-91.
PMID: 22645148
This study aimed to investigate the possible involvement of the orphan nuclear receptor chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) in the regulation of renin gene expression. COUP-TFII colocalized...
8.
Desch M, Schubert T, Schreiber A, Mayer S, Friedrich B, Artunc F, et al.
Mol Endocrinol
. 2010 Sep;
24(11):2139-51.
PMID: 20861226
The second messenger cAMP plays an important role in the regulation of renin gene expression. Nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ) is known to stimulate renin gene transcription acting through...
9.
Kastrati A, Dibra A, Mehilli J, Mayer S, Pinieck S, Pache J, et al.
Circulation
. 2006 May;
113(19):2293-300.
PMID: 16682614
Background: The efficacy of drug-eluting stents in reducing restenosis risk has not been uniform across patient subsets. Identifying predictive factors of restenosis may help improve outcomes after percutaneous coronary interventions....
10.
Dibra A, Ndrepepa G, Mehilli J, Pineck S, Mayer S, Bollwein H, et al.
Am J Cardiol
. 2005 Oct;
96(8):1113-5.
PMID: 16214448
The prognostic value of the newly defined impaired fasting glucose (IFG) range (100 to 109 mg/dl) for the outcomes of patients undergoing percutaneous coronary interventions is unknown. We assessed the...